Current filters:

Ferrer Internacional

1 to 9 of 11 results

Spanish pharma companies plan to continue extending their footprint around the world


Spanish pharmaceutical companies have developed a strong strategy in the last years to expand their products…

AlmirallCinfaEsteve GroupFerrer InternacionalGlobalGrifolsKern PharmaMarkets & MarketingPharmaceuticalPharmaMarSpain

Medimetriks licenses ozenoxacin, a novel antibacterial, from Ferrer


US specialty drug firm Medimetriks Pharmaceuticals has entered into a licensing agreement with Ferrer,…

Antibiotics and Infectious diseasesFerrer InternacionalLicensingMedimetriks PharmaceuticalsNorth AmericaOzenoxacinPharmaceuticalUSA

Ferrer links with Ildong and Ergomed for lorediplon development


Privately-held Spanish drugmaker Ferrer has executed two agreements, one with South Korea’s Ildong…

Asia-PacificErgomed Clinical ResearchFerrer InternacionalIldong PharmaLicensinglorediplonNeurologicalPharmaceuticalResearch

Planned expansion of anti-psychotic drug throughout Europe


Austrian drugmaker AOP Orphan and privately held Spanish drugmaker Ferrer Internacional are expanding…

AdasuveAOP OrphanEuropeFerrer InternacionalMarkets & MarketingNeurologicalPharmaceutical

Ferrer and Medivir join forces on Adasuve for Nordic markets


Sweden’s Medivir (Nasdaq OMX: MVIR) and privately-held Spanish drugmaker Ferrer Internacional have…

AdasuveAlexza PharmaceuticalEuropeFerrer InternacionalLicensingMedivirNeurologicalPharmaceutical

Ferrer's Ozenoxacin shows superiority in Ph III impetigo trial


Privately-held Spanish drugmaker Ferrer Internacional says that it has successfully completed a Phase…

Antibiotics and Infectious diseasesDermatologicalsFerrer InternacionalLicensingOzenoxacinPharmaceuticalResearch

Positive EU regulatory news for Alexza and Ferrer, but not Gentium


USA-based Alexza Pharmaceuticals (Nasdaq: ALXA) and Spanish partner Grupo Ferrer Internacional have received…

AdasuveAlexza PharmaceuticalBiotechnologydefibrotideEuropeFerrer InternacionalGentiumNephrology and HepatologyNeurologicalPharmaceuticalRegulation

Positive recommendations from EMA's CHMP for Selincro, Adasuve and Perjeta


Last week's deliberations of the European Medicines Agency's Committee for Medicinal Products for Human…

AdasuveAlexza PharmaceuticalBiotechnologyEuropeFerrer InternacionalLundbeckNeurologicalOncologyPerjetaPharmaceuticalRegulationRocheSelincro

1 to 9 of 11 results

Back to top